Psychological wellbeing in patients

Clinical Endocrinology

Volumn 57, Issue 5, 2002, Pages 575-576

  Ladenson, Paul W ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID HORMONE;

AUTOIMMUNITY; CHRONIC DISEASE; CONCENTRATION RESPONSE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; MEDICAL PRACTICE; MEMORY; NEUROPSYCHIATRY; NOTE; PRIORITY JOURNAL; PSYCHOLOGY; THINKING; WELLBEING;

HUMANS; HYPOTHYROIDISM; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 0036428317     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2002.01682.x     Document Type: Note

References (14)

1. Bunevicius, R. & Prange, A.J. (2000) Mental improvement after replacement therapy with thyroxine plus triiodothyronine: Relationship to cause of hypothyroidism. International Journal of Neuropsychopharmacology, 3, 167-174.
2. Bunevicius, R., Kaznavicius, G., Zalinkavicius, & Prage, A.J. Jr (1999) Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. New England Journal of Medicine, 340, 424-429.
3. Canaris, G.J., Manowitz, N.R., Mayor, G. & Ridgway, E.C. (2000) The Colorado disease prevalence study. Archives of Internal Medicine, 160, 526-534.
4. Canaris, G.J., Steiner, J.F. & Ridgway, E.C. (1997) Do traditional symptoms of hypothyroidism correlate with biochemical disease? Journal of General Internal Medicine, 12, 544-550.
5. Cooper, D.S., Halpern, R., Wood, L.C., Levin, A.A. & Ridgway, E.C. (1984) L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Annals of Internal Medicine, 101, 18-24.
6. Hallowell, J.G., Staehling, N.W., Flanders, W.D., Hannon, W.H., Guner, E.W., Spencer, C.A. & Braverman, L.E. (2002) Serum TSH, T (4), and thyroid antibodies in the United States population 1988-94. National Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology and Metabolism, 87, 489-499.
7. Haugen, B.R., Pacini, F., Reiners, C., Schlumberger, M., Ladenson, P.W., Sherman, S.I., Cooper, D.S., Samuels, M., Graham, K., Braverman, L.E., Skarulis, M., Davies, T.F., DeGroot, L.J., Mazzaferri, E.L., Daniels, G.H., Ross, D.S., Luster, M., Becker, D.V., Maxon, H.R., Cavalieri, R.R., Spencer, C.A., McEllin, K., Weintraub, B.D. & Ridgway, E.C. (1999) A comparison of recombinant thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. Journal of Clinical Endocrinology and Metabolism, 84, 3877-3885.
8. Ladenson, P.W., Braverman, L.E., Mazzaferri, E.L., Robbins, J., Cooper, D.S., Garber, J.S., Wondisford, F.E., Davies, T.F., DeGroot, L.J., Daniels, G.H., Ross, D.S., Levis, S., Hay, I.D., McEllin, K., Moscicki, R. & Weintraub, B.D. (1997) Comparison of recombinant human thyrotropin administration to thyroid hormone withdrawal for radioactive iodine scanning in patients with thyroid carcinoma. New England Journal of Medicine, 337, 888-896.
9. Parle, J.V., Franklyn, J.A., Cross, K.W., Jones, S.R. & Sheppard, M.C. (1993) Thyroxine prescription in the community: Serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. British Journal of General Practice, 43, 107-109.
10. Pollock, M.A., Sturrock, A., Marshall, K., Davidson, K.M., Kelly, C.J., McMahon, A.D. & McLaren, E.H. (2001) Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: Randomised double blind placebo controlled crossover trial. British Medical Journal, 323, 891-895.
11. Ross, D.S., Daniels, G.H. & Gouveia, D. (1990) The use and limitations of a chemiluminescent thyrotropin assay as a single thyroid function test in an out-patient endocrine clinic. Journal of Clinical Endocrinology and Metabolism, 71, 764-769.
12. Saravanan, P., Chau, F., Roberts, N., Vedhara, K., Greewood, R. & Dayan, C.M. (2002) Psychological well-being in patients on 'adequate' doses of L-thyroxine: Results of a large controlled community based questionnaire study. Clinical Endocrinology, 57, 577-585.
13. Staub, J.J., Althaus, B.U., Engler, H., Ryff, A.S., Trabucco, P., Marquardt, K., Burkhardt, D., Girard, J. & Weintraub, B.D. (1992) Spectrum of subclinical and overt hypothyroidism. Effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. American Journal of Medicine, 92, 631-642.
14. Tunbridge, W.M., Evered, D.C., Hall, R., Appleton, D., Brewis, M., Clark, F., Evans, J.G., Young, E., Bird, T. & Smith, P.A. (1977 December) The spectrum of thyroid disease in a community: The Whickham survey. Clinical Endocrinology, 7, 481-493.